Literature DB >> 18772463

Hypoparathyroidism: is it time for replacement therapy?

Mara J Horwitz, Andrew F Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18772463      PMCID： PMC2729233          DOI： 10.1210/jc.2008-1216

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Translational implications of the parathyroid calcium receptor.

Authors:  Andrew F Stewart
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

Review 2.  Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

Authors:  Armen H Tashjian; Robert F Gagel
Journal:  J Bone Miner Res       Date:  2005-11-11       Impact factor: 6.741

3.  On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

Authors:  Armen H Tashjian; David Goltzman
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

4.  Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

Authors:  K K Winer; J A Yanovski; G B Cutler
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

5.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Authors:  Karen K Winer; Chia Wen Ko; James C Reynolds; Karen Dowdy; Meg Keil; Donna Peterson; Lynn H Gerber; Charles McGarvey; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

8.  Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

Authors:  Karen K Winer; Ninet Sinaii; Donna Peterson; Bruno Sainz; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

9.  Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.

Authors:  R Lindsay; J Nieves; E Henneman; V Shen; F Cosman
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

10.  A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

Authors:  K K Winer; J A Yanovski; B Sarani; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958
  10 in total
  10 in total

1.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 2.  Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.

Authors:  Esther S Kim; Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

3.  Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Authors:  Karen K Winer; Andrea Kelly; Alicia Johns; Bo Zhang; Karen Dowdy; Lauren Kim; James C Reynolds; Paul S Albert; Gordon B Cutler
Journal:  J Pediatr       Date:  2018-12       Impact factor: 4.406

Review 4.  Hypocalcemia: updates in diagnosis and management for primary care.

Authors:  Jeremy Fong; Aliya Khan
Journal:  Can Fam Physician       Date:  2012-02       Impact factor: 3.275

5.  Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Authors:  Karen K Winer; Bo Zhang; Joseph A Shrader; Donna Peterson; Michaele Smith; Paul S Albert; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

Review 6.  A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review.

Authors:  Akshay Varghese; Eduardo Lacson; Jessica M Sontrop; Rey R Acedillo; Ahmed A Al-Jaishi; Sierra Anderson; Amit Bagga; Katie L Bain; Laura L Bennett; Clara Bohm; Pierre A Brown; Christopher T Chan; Brenden Cote; Varun Dev; Bonnie Field; Claire Harris; Shasikara Kalatharan; Mercedeh Kiaii; Amber O Molnar; Matthew J Oliver; Malvinder S Parmar; Melissa Schorr; Nikhil Shah; Samuel A Silver; D Michael Smith; Manish M Sood; Irina St Louis; Karthik K Tennankore; Stephanie Thompson; Marcello Tonelli; Hans Vorster; Blair Waldvogel; James Zacharias; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-10-22

7.  Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.

Authors:  Karen K Winer; Kara A Fulton; Paul S Albert; Gordon B Cutler
Journal:  J Pediatr       Date:  2014-06-16       Impact factor: 4.406

Review 8.  22q11 deletion syndrome: current perspective.

Authors:  Bülent Hacıhamdioğlu; Duygu Hacıhamdioğlu; Kenan Delil
Journal:  Appl Clin Genet       Date:  2015-05-18

9.  Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.

Authors:  Vimal Upreti; Shrikant Somani; Narendra Kotwal
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

10.  Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).

Authors:  Kristina S Chen; Elvira O Gosmanova; Gary C Curhan; Markus Ketteler; Mishaela Rubin; Elyse Swallow; Jing Zhao; Jessie Wang; Nicole Sherry; Alan Krasner; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.